T. Bardin, S. Bouee, P. Clerson, G. Chales, R. M. Flipo et al., Prevalence of Gout in the Adult Population of France, Arthritis Care Res (Hoboken), vol.68, issue.2, pp.261-267, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01187430

Y. Zhu, B. J. Pandya, and H. K. Choi, Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey, Arthritis Rheum, vol.63, issue.10, pp.3136-3177, 2007.

T. Pascart and F. Liote, Gout: state of the art after a decade of developments. Rheumatology (Oxford), 2018.

M. Doherty, New insights into the epidemiology of gout, Rheumatology (Oxford), p.48, 2009.

C. F. Kuo, M. J. Grainge, W. Zhang, and M. Doherty, Global epidemiology of gout: prevalence, incidence and risk factors, Nat Rev Rheumatol, vol.11, issue.11, pp.649-62, 2015.

P. Richette, M. Doherty, E. Pascual, V. Barskova, F. Becce et al., updated EULAR evidence-based recommendations for the management of gout, Ann Rheum Dis, vol.76, issue.1, pp.29-42, 2016.

M. Hui, A. Carr, S. Cameron, G. Davenport, M. Doherty et al., The British Society for Rheumatology Guideline for the Management of Gout, Rheumatology, 2017.

C. C. Lu, S. K. Wu, H. Y. Chen, W. S. Chung, M. C. Lee et al., Clinical characteristics of and relationship between metabolic components and renal function among patients with early-onset juvenile tophaceous gout, J Rheumatol, vol.41, issue.9, pp.1878-83, 2014.

K. H. Yu and S. F. Luo, Younger age of onset of gout in Taiwan, Rheumatology (Oxford), vol.42, issue.1, pp.166-70, 2003.

B. Zhang, W. Fang, X. Zeng, Y. Zhang, Y. Ma et al., Clinical characteristics of early-and late-onset gout: A cross-sectional observational study from a Chinese gout clinic, Medicine (Baltimore), vol.95, issue.47, p.5425, 2016.

F. Liote, S. Lancrenon, S. Lanz, P. Guggenbuhl, C. Lambert et al., GOSPEL: prospective survey of gout in France. Part I: design and patient characteristics (n = 1003), Joint Bone Spine, vol.79, issue.5, pp.464-70, 2012.

K. G. Alberti, R. H. Eckel, S. M. Grundy, P. Z. Zimmet, J. I. Cleeman et al., Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute, Circulation, vol.120, issue.16, pp.1640-1645, 2009.

A. S. Levey, K. U. Eckardt, Y. Tsukamoto, A. Levin, J. Coresh et al., Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, vol.67, issue.6, pp.2089-100, 2005.

A. S. Levey, P. E. Jong, J. Coresh, E. Nahas, M. Astor et al., The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report, Kidney Int, vol.80, issue.1, pp.17-28, 2011.

D. Bursill, W. J. Taylor, R. Terkeltaub, M. Kuwabara, T. R. Merriman et al., Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in gout, Arthritis Care Res, vol.75, issue.4, pp.652-661, 2016.

C. Lahaye, F. Auge, and M. Soubrier, Ceballos-Picot I. New mutation affecting hypoxanthine phosphoribosyltransferase responsible for severe tophaceous gout, J Rheumatol, vol.41, issue.6, pp.1252-1256, 2014.

T. R. Merriman, An update on the genetic architecture of hyperuricemia and gout, Arthritis Res Ther, vol.17, p.98, 2015.

H. Matsuo, K. Ichida, T. Takada, A. Nakayama, H. Nakashima et al., Common dysfunctional variants in ABCG2 are a major cause of early-onset gout, Curr Opin Rheumatol, vol.3, issue.2, pp.156-60, 2011.

E. S. Ford, W. H. Giles, and W. H. Dietz, Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey, JAMA, vol.287, issue.3, pp.356-365, 2002.

I. Wakabayashi, Association between alcohol drinking and metabolic syndrome in Japanese male workers with diabetes mellitus, J Atheroscler Thromb, vol.18, issue.8, pp.684-92, 2011.

L. Jin, Y. Huang, Y. Bi, L. Zhao, M. Xu et al., Association between alcohol consumption and metabolic syndrome in 19,215 middle-aged and elderly Chinese, Diabetes Res Clin Pract, vol.92, issue.3, pp.386-92, 2011.

V. G. Athyros, E. N. Liberopoulos, D. P. Mikhailidis, A. A. Papageorgiou, E. S. Ganotakis et al., Association of drinking pattern and alcohol beverage type with the prevalence of metabolic syndrome, diabetes, coronary heart disease, stroke, and peripheral arterial disease in a Mediterranean cohort, Angiology, vol.58, issue.6, pp.689-97, 2007.

P. Richette, F. Perez-ruiz, M. Doherty, T. L. Jansen, G. Nuki et al., Improving cardiovascular and renal outcomes in gout: what should we target?, Nat Rev Rheumatol, vol.10, issue.11, pp.654-61, 2014.

A. Abhishek, A. M. Valdes, W. Zhang, and M. Doherty, Association of Serum Uric Acid and Disease Duration With Frequent Gout Attacks: A Case-Control Study, Arthritis Care Res (Hoboken), vol.68, issue.10, pp.1573-1580, 2016.

S. L. Wallace, H. Robinson, A. T. Masi, J. L. Decker, D. J. Mccarty et al., Preliminary criteria for the classification of the acute arthritis of primary gout, Arthritis Rheum, vol.20, issue.3, pp.895-900, 1977.

T. Neogi, T. L. Jansen, N. Dalbeth, J. Fransen, H. R. Schumacher et al., Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative, Ann Rheum Dis, vol.74, issue.10, pp.1789-98, 2015.